Lurbinectedin et al
Jun 18, 2020•18 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Topics on this week's Pod include:
-Lurbinectedin in SCLC
-Nivolumab is esophageal cancer
-Pembrolizumab for TMB-high cancers
-Gemtuzumab ozogamicin for pediatric AML
-Venetoclax + HMA for adult (unfit) AML
-Gardasil for prevention of SCCHN
-Perhaps the biggest non-oncopharm news of the year?
For the best experience, listen in Metacast app for iOS or Android